Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in GGBXF in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a GGBXF trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| May 24, 2020 | Moore (Timothy David)Director of Issuer | Acquisition or disposition in the public market at price 0.01 per share. | 318.3K | $2.23K |
| May 24, 2020 | Moore (Timothy David)Director of Issuer | Acquisition or disposition in the public market at price 0.01 per share. | 49.5K | $346 |
| May 24, 2020 | Moore (Timothy David)Director of Issuer | Acquisition or disposition in the public market at price 0.01 per share. | 19K | $133 |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2024 | 0.0 | 0.0 | 900.0 | -90.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −0.0% |
| 2023 | 0.0 | 0.0 | -80.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −80.0% |
| 2022 | 0.0 | -90.0 | 900.0 | -90.0 | 900.0 | -90.0 | 0.0 | 900.0 | -90.0 | 0.0 | 900.0 | -50.0 | −50.0% |
| 2021 | 148.0 | -14.9 | -17.5 | -75.2 | -14.6 | -21.4 | 36.4 | -26.7 | -98.2 | 0.0 | 100.0 | -50.0 | −99.5% |
| 2020 | -41.8 | -41.2 | -60.8 | -37.2 | -72.5 | 21.5 | 27.5 | 15.2 | -1.8 | -25.7 | 15.1 | -11.0 | −96.9% |
| 2019 | 18.3 | -8.1 | -6.1 | 1.5 | -22.6 | -20.4 | -25.5 | -26.1 | -16.7 | 22.0 | -22.1 | -35.5 | −82.1% |
| 2018 | 31.2 | 2.6 | 0.0 | 0.0 | 0.0 | 257.2 | 32.6 | +537.2% |
No analyst coverage for this instrument.
Green Growth Brands Inc., together with its subsidiaries, engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabidiol (CBD)-infused consumer products in the United States. It provides medical and retail marijuana products to various dispensaries and CBD-infused personal care and beauty products, such as therapeutic, face care, body care, shower and bathroom, and sleep products, through shops, e-commerce, and wholesale channels. The company offers its products under the CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne brand names. The company was formerly known as Xanthic Biopharma Inc. and changed its name to Green Growth Brands Inc. in January 2019. Green Growth Brands Inc. was founded in 1968 and is based in Columbus, Ohio.
No recent headlines.